ArticleCell chemical biology2026

Small-molecule inhibitors of the protein kinase DYRK as potential therapeutic candidates in cancer.

Prabhadevi Venkataramani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.